Where does Bionomics Limited rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), Bionomics Limited ranks #8,543 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does Bionomics Limited hold?

Bionomics Limited holds 37 US utility patents granted between 2015 and 2025, spanning 9 technology areas.

What is Bionomics Limited's Innovation Score?

Bionomics Limited has an Innovation Score of 36.6 out of 100 (top 46% of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does Bionomics Limited focus on?

Bionomics Limited's top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 34 patents, ranking #560 of 6,058 assignees active in that subclass. Grants appear in 9 CPC subclasses total.

Is Bionomics Limited's patent grant rate increasing or decreasing?

Bionomics Limited's recent grant velocity is -60% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for Bionomics Limited's patents?

Bionomics Limited's patents average 15.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the Bionomics Limited patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

Bionomics Limited

USPTO PatentsView assignee record - 37 granted patents across 9 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Bionomics ranks #8,543 of 49,997 tracked US assignees by granted-patent volume, with 37 patents across 9 technology areas.

#8,543
of 49,997 US assignees by volume: Top 46%
by Innovation Score (36.6/100): 15.8
avg claims per patent: -60%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R8543 · Foreign Corporation #8,543 · 37 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 37 grants
UPPER-Q #8,543/49,997
PHOTO-FINISH Beijing Tenafe…
CPC-NARROW A61P · 9 areas
INNOV-THIN 36.6/100
CLAIMS-RICH 15.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -60% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Beijing Tenafe Electronic Technology Co., Ltd. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Bionomics’s 36.6 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 12.6 pts (34%) Velocity 4.0 pts (11%) Breadth 10.6 pts (29%) Claim depth 9.5 pts (26%)

Qualcomm Incorporated · highest

85
AIC · near

37
Bionomics · this assignee

37
Guill Tool &… · near

37
Kenvue Brands · near

37
Zest IP Holdings · near

37
3D Lighting… · lowest

7

What this shows Bionomics's Innovation Score is 36.6/100 (top 46% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Bionomics?

Each dot is one of Bionomics’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Bionomics’s own 15.8 claims/patent is at or below the 17.1 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Bionomics vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Bionomics's grants concentrate

Bionomics Limited is a focused PatentsView assignee: 9 CPC subclasses with 91.9% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2015 (7 grants) versus a trough of 1 in 2021. By volume, Bionomics sits between Beijing Tenafe Electronic Technology Co., Ltd. and CALOR.

Bionomics's three-year grant acceleration

Bionomics Limited shows 6 grants in 2022–2024 against only 10 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Beijing Tenafe Te…

37
Bercom Internatio…

37
Bitmicro Networks

37
Biocompatibles UK

37
Blazer and Flip F…

37
Broncus Medical

37
CA Casyso

37
Calor

37
Bionomics ◀

37

What this shows Bionomics holds 37 patents at rank #8,545, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near Bionomics

By rank, the assignees closest to #8,545 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in Bionomics's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for Bionomics, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Bionomics ranks #560 of 6,058 assignees by patent count in that subclass.

Similar innovation score

Nearest assignees by Innovation Score (37 here).

Guill Tool & Engineering Co., Inc. 37 AIC Inc. 37 Zest IP Holdings, LLC 37 Kenvue Brands LLC 37

Bionomics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

37 Top 46% higher than 54% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

Bionomics Limited patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	7	18.9%
2016	2	5.4%
2017	5	13.5%
2018	5	13.5%
2019	6	16.2%
2020	3	8.1%
2021	1	2.7%
2022	2	5.4%
2023	1	2.7%
2024	3	8.1%
2025partial year	2	5.4%

Which technologies does Bionomics Limited patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 34

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 27

C07D - Heterocyclic Compounds 19

C07K - Peptides 12

C07C - Acyclic OR Carbocyclic Compounds 5

G01N - Investigating OR Analysing Materials BY Determining Their Chemical OR Physical Properties 4

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 2

C12Q - Measuring OR Testing Processes Involving Enzymes, Nucleic Acids OR Microorganisms ; Compositions OR Test Papers THEREFOR; Processes OF Preparing Such COMPOSITIONS; Condition-responsive Control IN Microbiological OR Enzymological Processes 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

Top 9 of 9 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

Bionomics Limited's patent record in context - here's where to go next.

Bionomics Limited's lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.9% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #8,543 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare Bionomics Limited against Beijing Tenafe Electronic Technology Co., Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 36.6/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.